Yale’s Antibody-RNA Therapy: Tackling Treatment Resistant Cancers Recent advances at Yale are reshaping the fight against some of the toughest cancers. Researchers have engineered a unique antibody-RNA therapy that offers renewed hope for patients where traditional ... antibody-RNA cancer therapy clinical trials immunotherapy precision medicine resistant tumors Yale research
Roche's Trontinemab Raises the Bar for Alzheimer's Amyloid Clearance Alzheimer’s disease treatments may be on the cusp of a major breakthrough, thanks to Roche’s innovative antibody, trontinemab . This next-generation therapy has shown remarkable speed and effectivenes... Alzheimer’s amyloid plaques blood-brain barrier clinical trials drug development neurodegeneration trontinemab
Repurposed Cancer Drugs Show Promise Against Alzheimer’s Brain Damage Could the answer to reversing Alzheimer’s brain damage already exist on pharmacy shelves? Recent research points to a surprising possibility: some cancer drugs may help fight the devastating effects o... Alzheimer's brain health cancer drugs clinical trials drug repurposing gene expression irinotecan letrozole
GLP-1s: A Promising Frontier in Neurodegenerative Disease Treatment The recent surge in interest around GLP-1 receptor agonists has opened up exciting new avenues in medical science. Originally celebrated for their impact on diabetes and obesity, these medications are... Alzheimer’s brain health clinical trials GLP-1 neurodegeneration neuroprotection Parkinson’s
Yale Once-Monthly Obesity Medication Is A Potential Treatment for Weight Loss For millions living with obesity and type 2 diabetes, medication adherence can be a constant struggle. Now, new research points to a future where a single monthly injection could replace the current w... clinical trials GLP-1 medications MariTide obesity pharmaceuticals type 2 diabetes weight loss Yale research
Video Games Could Transform Early Detection of Alzheimer’s Disease Envision a world where playing a video game could reveal Alzheimer’s disease years before symptoms appear. Researchers at Rutgers-Newark are pioneering this possibility, developing computerized games ... Alzheimer's blood tests brain health clinical trials cognitive testing early detection inclusive research video games
FDA’s Shift Away from Animal Testing: A New Era in Drug Development The pharmaceutical landscape is on the verge of a significant transformation as the FDA embarks on a journey to phase out animal testing in favor of innovative, human-relevant alternatives. This strat... animal testing biotechnology clinical trials drug development FDA organ chips pharmaceuticals